Monday, 21 September 2020
BMC publishes series of IDDO papers about the causes of non-malarial febrile illnesses globally
A series of articles that set out to explore the global distribution of infections that cause non-malarial febrile illness (NMFI) has today been published in BMC Medicine.The series brings together the results of large-scale systematic reviews of the causes of fever in Africa, Latin America, and Sou...
Monday, 14 September 2020
Professor Paul Newton wins the Helen Clark-JoPPP Award
We are delighted to announce that Professor Paul Newton has won the Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. Professor Newton has been presented with the award based on the scientific merit of his work, as well as its impact on patients, decisions makers, and on g...
Thursday, 10 September 2020
Microscopy standards to harmonise methods for malaria clinical research studies
Research Malaria Microscopy Standards (ReMMS) applicable to malaria clinical research studies have been published in Malaria Journal. The paper describes the rationale for proposed standards to prepare, stain and examine blood films for malaria parasites.
Thursday, 13 August 2020
New six-month report flags growing number of medical product quality concerns relating to COVID-19
The Medicine Quality Research Group has published a six-month Medical Product Quality Report focused on COVID-19 today, using its Medicine Quality Monitoring Globe tool. New reports will be issued monthly from now on, following the first January - June publication.
Tuesday, 21 July 2020
New online tool to fill information gaps in substandard and falsified medicines
A major challenge in preventing, detecting and responding to substandard and falsified (SF) medical products is the lack of accessible and reliable information on how widespread the problem is and where. SF medical products, which includes medicines, vaccines, diagnostic tests and devices, pose an i...
Wednesday, 15 July 2020
COVID-19 Data Platform Data Access Committee - call for nominations
Nominations for members of the COVID-19 Data Platform Data Access Committee are now open. Please consider nominating individuals to contribute expertise to this pioneering collaboration in COVID-19 and emerging infections research to firstname.lastname@example.org by 31 July 2020.
Wednesday, 17 June 2020
Tribute to Professor Marleen Boelaert
It is with great sadness that IDDO has learnt of the passing of Professor Marleen Boelaert, a valued member of the IDDO team since 2017. Professor Boelaert’s research concentrated on the control of tropical infectious diseases, mainly leishmaniasis and sleeping sickness.
Wednesday, 3 June 2020
More time to comment on draft Research Agenda
IDDO has extended the feedback period on its draft Research Agenda on schistosomiasis and soil-transmitted helminthiases (STHs) until July 17. Comments are welcome from the wider research community to help form the direction of research work using IDDO’s schistosomiasis and STHs data platform.
Friday, 22 May 2020
New global collaboration developing standards for standardised data collection across the VL research community
Visceral leishmaniasis (VL), also known as kala-azar, is transmitted to humans through the bites from infected female phlebotomine sand flies. If left untreated, it is fatal in 95% of cases. Globally, it is estimated there are up to 22,000 new cases of VL each year which occur in Brazil, Ethiopia, I...
Wednesday, 29 April 2020
New evidence for optimising malaria treatment in pregnant women
The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN umbrella. The study found that artemether-lumefantrine (AL) and other artemis...
Thursday, 9 April 2020
Global call for strategic planning for COVID-19 medical products
Global health experts have united in a call for governments and international organisations around the world to plan strategically for the coordinated production, equitable distribution and surveillance of COVID-19 medical products to ensure access to quality-assured medications for everyone.
Thursday, 2 April 2020
Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings. The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research i...
Monday, 30 March 2020
First global tool to track news reports of substandard and falsified medical products is live
The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data.